Karyopharm Therapeutics, Inc. (KPTI)
9.105
0.00 (0.00%)
USD |
NASDAQ |
Jun 11, 12:24
Karyopharm Therapeutics 1 Year Total Returns (Daily) : 105.6% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 105.6% |
| June 09, 2026 | 106.4% |
| June 08, 2026 | 89.31% |
| June 05, 2026 | 113.1% |
| June 04, 2026 | 109.0% |
| June 03, 2026 | 111.8% |
| June 02, 2026 | 124.0% |
| June 01, 2026 | 133.8% |
| May 29, 2026 | 100.9% |
| May 28, 2026 | 103.3% |
| May 27, 2026 | 97.36% |
| May 26, 2026 | 95.42% |
| May 22, 2026 | 75.86% |
| May 21, 2026 | 71.49% |
| May 20, 2026 | 54.80% |
| May 19, 2026 | 45.76% |
| May 18, 2026 | 34.21% |
| May 15, 2026 | 40.99% |
| May 14, 2026 | 83.51% |
| May 13, 2026 | 79.88% |
| May 12, 2026 | 44.96% |
| May 11, 2026 | 46.59% |
| May 08, 2026 | 40.49% |
| May 07, 2026 | 44.84% |
| May 06, 2026 | 43.86% |
| Date | Value |
|---|---|
| May 05, 2026 | 32.72% |
| May 04, 2026 | 26.36% |
| May 01, 2026 | 29.73% |
| April 30, 2026 | 23.11% |
| April 29, 2026 | 32.28% |
| April 28, 2026 | 41.68% |
| April 27, 2026 | 54.09% |
| April 24, 2026 | 45.06% |
| April 23, 2026 | 39.55% |
| April 22, 2026 | 58.37% |
| April 21, 2026 | 69.81% |
| April 20, 2026 | 80.61% |
| April 17, 2026 | 73.94% |
| April 16, 2026 | 95.93% |
| April 15, 2026 | 100.9% |
| April 14, 2026 | 100.7% |
| April 13, 2026 | 93.01% |
| April 10, 2026 | 100.5% |
| April 09, 2026 | 92.91% |
| April 08, 2026 | 83.08% |
| April 07, 2026 | 78.47% |
| April 06, 2026 | 63.73% |
| April 02, 2026 | 45.07% |
| April 01, 2026 | 64.41% |
| March 31, 2026 | 48.93% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Gilead Sciences, Inc. | 13.29% |
| Catalyst Pharmaceuticals, Inc. | 19.12% |
| Incyte Corp. | 50.41% |
| Inovio Pharmaceuticals, Inc. | -51.56% |
| Cellectar Biosciences, Inc. | -79.41% |